Simple Theoretical Criterion for Selection of Natural Compounds with Anti-COVID-19 Activity.

IF 3.1 4区 生物学 Q2 Immunology and Microbiology Frontiers in Bioscience-Landmark Pub Date : 2022-05-11 DOI:10.31083/j.fbl2705152
V. Veljkovic, S. Glišić, V. Perovic, M. Veljkovic, S. Paessler
{"title":"Simple Theoretical Criterion for Selection of Natural Compounds with Anti-COVID-19 Activity.","authors":"V. Veljkovic, S. Glišić, V. Perovic, M. Veljkovic, S. Paessler","doi":"10.31083/j.fbl2705152","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nA novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the leading threat to global health. An effective antiviral could not only help those still vulnerable to the virus but could be a critical treatment if a virus emerges toward evading coronavirus disease 2019 (COVID-19) vaccines. Despite the significant efforts to test already-approved drugs for their potential to kill the virus, researchers found very few actually worked.\n\n\nMETHODS\nThe present report uses the electronic molecular descriptors, the quasi-valence number (AQVN), and the electron-ion interaction potential (EIIP), for the analysis of natural compounds with proven therapeutic activity against the COVID-19.\n\n\nRESULTS\nBased on the analysis of the electronic properties of natural compounds which are effective against SARS-CoV-2 virus the simple theoretical criterion for the selection of candidate compounds for the treatment of COVID-19 is proposed.\n\n\nCONCLUSIONS\nThe proposed theoretical criterion can be used for the identification and optimization of new lead compounds for the treatment of the COVID-19 disease and for the selection of the food and food supplements which could have a beneficial effect on COVID-19 patients.","PeriodicalId":50430,"journal":{"name":"Frontiers in Bioscience-Landmark","volume":null,"pages":null},"PeriodicalIF":3.1000,"publicationDate":"2022-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioscience-Landmark","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.31083/j.fbl2705152","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

BACKGROUND A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become the leading threat to global health. An effective antiviral could not only help those still vulnerable to the virus but could be a critical treatment if a virus emerges toward evading coronavirus disease 2019 (COVID-19) vaccines. Despite the significant efforts to test already-approved drugs for their potential to kill the virus, researchers found very few actually worked. METHODS The present report uses the electronic molecular descriptors, the quasi-valence number (AQVN), and the electron-ion interaction potential (EIIP), for the analysis of natural compounds with proven therapeutic activity against the COVID-19. RESULTS Based on the analysis of the electronic properties of natural compounds which are effective against SARS-CoV-2 virus the simple theoretical criterion for the selection of candidate compounds for the treatment of COVID-19 is proposed. CONCLUSIONS The proposed theoretical criterion can be used for the identification and optimization of new lead compounds for the treatment of the COVID-19 disease and for the selection of the food and food supplements which could have a beneficial effect on COVID-19 patients.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
抗covid -19活性天然化合物选择的简单理论准则。
人类新型冠状病毒——严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)已成为全球健康的主要威胁。有效的抗病毒药物不仅可以帮助那些仍然易受病毒感染的人,而且如果病毒出现以逃避2019冠状病毒病(COVID-19)疫苗,可能是一种关键的治疗方法。尽管研究人员付出了巨大的努力来测试已经批准的药物是否有可能杀死病毒,但他们发现,真正有效的药物很少。方法采用电子分子描述符、准价数(AQVN)和电子-离子相互作用势(EIIP)对已证实具有抗COVID-19治疗活性的天然化合物进行分析。结果在分析抗SARS-CoV-2病毒有效天然化合物电子特性的基础上,提出了选择候选化合物治疗COVID-19的简单理论准则。结论所建立的理论标准可用于新冠肺炎治疗先导化合物的鉴定和优化,以及对新冠肺炎患者有益的食品和食品补充剂的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Bioscience-Landmark
Frontiers in Bioscience-Landmark 生物-生化与分子生物学
CiteScore
3.40
自引率
3.20%
发文量
301
审稿时长
3 months
期刊介绍: FBL is an international peer-reviewed open access journal of biological and medical science. FBL publishes state of the art advances in any discipline in the area of biology and medicine, including biochemistry and molecular biology, parasitology, virology, immunology, epidemiology, microbiology, entomology, botany, agronomy, as well as basic medicine, preventive medicine, bioinformatics and other related topics.
期刊最新文献
Bulimia Nervosa and Depression, from the Brain to the Gut Microbiota and Back Exosomal miR-423-5p Derived from Mineralized Osteoblasts Promotes Angiogenesis of Endothelial Cells by Targeting CXCL10 Role of Podocyte in Kidney Disease Exploring the Link between Metabolic Remodelling and Reactive Oxygen Species in the Aged and Diseased Heart Molecular Regulation of Bone Turnover in Juvenile Idiopathic Arthritis: Animal Models, Cellular Features and TNFα
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1